[Update in interleukin-1 inhibition].

doi:10.1016/j.revmed.2012.01.012

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

[Update in interleukin-1 inhibition].

La Revue de medecine interne - 1 Apr 2012

de Boysson H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Cryopyrin-Associated Periodic Syndromes
Share to Erdheim-Chester Disease
Share to Familial Mediterranean Fever

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-1

Share to Interleukin 1 Receptor Antagonist Protein

Share to Interleukin-1alpha

Share to NLR Family, Pyrin Domain-Containing 3 Protein

Source

Open in PubMed

Identifiers

PMID: 22360831
DOI: 10.1016/j.revmed.2012.01.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Update in interleukin-1 inhibition].PMID 22360831Read ↗

[Cytokine signaling].Semantic proximity Read ↗

[IV. Development and Future Perspective of Immune Checkpoint Blockade Therapy].Semantic proximity Read ↗

An Expanding Role for Interleukin-1 Blockade from Gout to CancerSemantic proximity Read ↗

[New clinical evidence and drugs].Semantic proximity Read ↗

Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseasesSemantic proximity Read ↗

[Perspectives and future developments of epidermal growth factor receptors inhibitors].Semantic proximity Read ↗

CD90.Semantic proximity Read ↗

[Individualized drug therapy].Semantic proximity Read ↗

Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory SoupSemantic proximity Read ↗

A primer on cytokines: sources, receptors, effects, and inducers.Semantic proximity Read ↗

Interleukin-20.Semantic proximity Read ↗

[Innate immunity and toll-like receptor].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.